Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Apr-24 4:35 PM View:  | Crombez Eric EVP and Chief Medical Officer | Ultragenyx Pharmaceutical I... (RARE) | 18-Apr-24 | Sale | 142 | $44.10 | $6,262.20 | (< 1%) 48.93K to 48.78K | |
| 18-Apr-24 6:06 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 16-Apr-24 | Payment of Exercise | 14 | $42.31 | $592.34 | (< 1%) 41.38K to 41.37K | |
| 12-Mar-24 1:41 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 11-Mar-24 | Sale | 11,509 | $49.93 | $574,644.00 | (4%) 264.33K to 252.82K | |
| 11-Mar-24 12:54 PM View: | Fust Matthew K Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Mar-24 | Sale | 12,195 | $50.88 | $620,443.00 | (45%) 27.05K to 14.86K | |
| 05-Mar-24 8:13 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 341 | $53.76 | $18,332.20 | (< 1%) 41.72K to 41.38K | |
| 05-Mar-24 8:08 PM View: | Harris Erik EVP & Chief Commercial Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 4,768 | $53.76 | $256,328.00 | (7%) 71.93K to 67.16K | |
| 05-Mar-24 8:19 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 18,757 | -- | -- | 8% 246.86K to 265.62K | |
| 05-Mar-24 8:06 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Payment of Exercise | 17,417 | $53.69 | $935,119.00 | (< 1%) 2.85M to 2.83M | |
| 05-Mar-24 8:15 PM View: | Pinion John Richard See Remarks | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Payment of Exercise | 60 | $53.69 | $3,221.40 | (< 1%) 93.5K to 93.44K | |
| 05-Mar-24 8:17 PM View: | Huang Dennis Karl See Remarks | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Payment of Exercise | 470 | $53.69 | $25,234.30 | (< 1%) 83.47K to 83.0K | |
| 05-Mar-24 8:10 PM View: | Crombez Eric EVP and Chief Medical Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 1,238 | $53.76 | $66,554.90 | (2%) 50.16K to 48.93K | |
| 05-Mar-24 8:13 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 13,950 | -- | -- | 50% 27.89K to 41.84K | |
| 05-Mar-24 8:19 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Payment of Exercise | 274 | $53.69 | $14,711.10 | (< 1%) 265.62K to 265.34K | |
| 05-Mar-24 8:22 PM View: | Parschauer Karah Herdman EVP and Chief Legal Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 18,757 | -- | -- | 36% 52.34K to 71.1K | |
| 05-Mar-24 8:15 PM View: | Pinion John Richard See Remarks | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 4,173 | $53.76 | $224,340.00 | (4%) 93.44K to 89.27K | |
| 05-Mar-24 8:13 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Payment of Exercise | 121 | $53.69 | $6,496.49 | (< 1%) 41.84K to 41.72K | |
| 05-Mar-24 8:08 PM View: | Harris Erik EVP & Chief Commercial Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 20,357 | -- | -- | 39% 51.57K to 71.93K | |
| 05-Mar-24 8:19 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 1,011 | $53.76 | $54,351.40 | (< 1%) 265.34K to 264.33K | |
| 05-Mar-24 8:06 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 41,560 | -- | -- | 1% 2.8M to 2.85M | |
| 05-Mar-24 8:22 PM View: | Parschauer Karah Herdman EVP and Chief Legal Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 3,756 | $53.76 | $201,923.00 | (5%) 71.1K to 67.34K | |
| 05-Mar-24 8:15 PM View: | Pinion John Richard See Remarks | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 18,757 | -- | -- | 25% 74.74K to 93.5K | |
| 05-Mar-24 8:17 PM View: | Huang Dennis Karl See Remarks | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 18,757 | -- | -- | 29% 64.72K to 83.47K | |
| 05-Mar-24 8:10 PM View: | Crombez Eric EVP and Chief Medical Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 19,400 | -- | -- | 63% 30.77K to 50.16K | |
| 05-Mar-24 8:23 PM View: | Horn Howard Chief Financial Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 19,400 | -- | -- | 24% 80.37K to 99.77K | |
| 08-Feb-24 3:49 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Feb-24 | Sale (Planned) | 30,000 | $45.00 | $1,350,000.00 | (1%) 2.83M to 2.8M | |
| 02-Jan-24 4:06 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 02-Jan-24 | Option Exercise | 3,000 | $21.00 | $63,000.00 | 12% 24.89K to 27.89K | |
| 02-Jan-24 4:07 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 29-Dec-23 | Sale (Planned) | 30,000 | $47.87 | $1,436,100.00 | (1%) 2.86M to 2.83M | |
| 02-Jan-24 4:06 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 20-Dec-23 | Grant | 1,000 | -- | -- | 4% 23.61K to 24.61K | |
| 24-Oct-23 5:22 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 23-Oct-23 | Option Exercise | 39,878 | $6.86 | $273,563.00 | 16% 246.86K to 286.74K | |
| 24-Oct-23 5:22 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 23-Oct-23 | Option Sale | 39,878 | $32.78 | $1,307,200.00 | (14%) 286.74K to 246.86K | |
| 23-Oct-23 5:14 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 19-Oct-23 | Option Sale | 47,853 | $33.52 | $1,604,030.00 | (2%) 2.91M to 2.86M | |
| 23-Oct-23 5:14 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 19-Oct-23 | Option Exercise | 47,853 | $6.86 | $328,272.00 | 2% 2.86M to 2.91M | |
| 11-Sep-23 1:52 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 07-Sep-23 | Sale | 163 | $40.80 | $6,650.33 | (< 1%) 23.78K to 23.61K | |
| 11-Sep-23 1:52 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 07-Sep-23 | Option Exercise | 2,000 | $21.00 | $42,000.00 | 8% 23.78K to 25.78K | |
| 11-Sep-23 1:52 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 07-Sep-23 | Option Sale | 2,000 | $40.80 | $81,599.10 | (8%) 25.78K to 23.78K | |
| 06-Sep-23 5:51 PM View: | Harris Erik EVP & Chief Commercial Officer | Ultragenyx Pharmaceutical I... (RARE) | 05-Sep-23 | Sale | 6,000 | $37.96 | $227,760.00 | (10%) 57.28K to 51.28K | |
| 06-Sep-23 5:50 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Sep-23 | Sale | 87 | $38.23 | $3,326.01 | (< 1%) 24.75K to 24.66K | |
| 06-Sep-23 5:50 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Sep-23 | Sale (Planned) | 883 | $37.04 | $32,706.30 | (4%) 24.66K to 23.78K | |
| 30-Jun-23 2:34 PM View: | Sanders Corazon (corsee) D. Director | Ultragenyx Pharmaceutical I... (RARE) | 30-Jun-23 | Sale (Planned) | 585 | $46.76 | $27,354.60 | (6%) 9.57K to 8.98K | |
| 21-Jun-23 6:17 PM View: | Harris Erik EVP & Chief Commercial Officer | Ultragenyx Pharmaceutical I... (RARE) | 19-Jun-23 | Sale | 305 | $48.20 | $14,701.00 | (< 1%) 57.59K to 57.28K | |
| 09-Jun-23 2:31 PM View: | Sanders Corazon (corsee) D. Director | Ultragenyx Pharmaceutical I... (RARE) | 08-Jun-23 | Sale (Planned) | 1,485 | $51.65 | $76,700.20 | (13%) 11.05K to 9.57K | |
| 09-Jun-23 2:30 PM View: | Narachi Michael Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Grant | 3,860 | -- | -- | 22% 17.75K to 21.61K | |
| 09-Jun-23 2:32 PM View: | Fust Matthew K Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Grant | 3,860 | -- | -- | 15% 26.5K to 30.36K | |
| 09-Jun-23 2:33 PM View: | Ray Amrit Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Grant | 3,860 | -- | -- | 46% 8.42K to 12.28K | |
| 09-Jun-23 2:31 PM View: | Sanders Corazon (corsee) D. Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Grant | 3,860 | -- | -- | 54% 7.2K to 11.05K | |
| 09-Jun-23 2:32 PM View: | Fust Matthew K Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Disposition | 3,300 | $51.82 | $171,006.00 | (11%) 30.36K to 27.05K | |
| 09-Jun-23 2:29 PM View: | Dunsire Deborah Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Grant | 3,860 | -- | -- | 24% 15.87K to 19.73K | |
| 09-Jun-23 2:30 PM View: | Suliman Shehnaaz Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Grant | 3,860 | -- | -- | 35% 10.99K to 14.86K | |
| 09-Jun-23 2:28 PM View: | Welch Daniel G Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Grant | 3,860 | -- | -- | 22% 17.75K to 21.61K | |
| 19-May-23 1:54 PM View: | Pinion John Richard See Remarks | Ultragenyx Pharmaceutical I... (RARE) | 18-May-23 | Sale (Planned) | 2,012 | $50.00 | $100,600.00 | (3%) 76.76K to 74.74K |
